[The role and method of fluorescence-guided cystoscopy in 2011 for management of bladder cancer: Review of the Oncology Committee of the French Urology Association].

Date publication

novembre 2011

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ROY Catherine

Tous les auteurs :
Wallerand H, Roupret M, Larre S, Houede N, Neuzillet Y, Comperat E, Quintens H, Pignot G, Roy C, Soulie M, Pfister C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/22035906

Résumé

AIM: Fluorescence-guided cystoscopy is a useful tool for bladder tumour detection in association with white-light cystoscopy and decreases the residual tumour rate. The aim of the study was to provide an overview of the pertinent literature on this subject. MATERIALS AND METHODS: The data were provide from a Medline((R)) research by using the follow keywords: urinary bladder neoplasms; cystoscopy; fluorescence; prognosis; intraepithelial neoplasm. RESULTS: No evidence 1 level data was available. The fluorescence-guided cystoscopy improves the bladder cancer detection rate, especially the flat lesions, and improve the recurrence-free survival by decreasing the residual tumour rate. The specific indications for fluorescence-guided cystoscopy in the diagnosis and management of non-muscle invasive bladder cancer (NMIBC) should benefit the patients. CONCLUSION: The fluorescence-guided cystoscopy is a benefical tool in association with white-light cystoscopy in NMIBC diagnosis. It has been shown to have a positive impact on recurrence-free survival but not on progression-free survival. More investigations with significant follow-up should be lead in the future to accurately assess its therapeutic impact on patients.

Référence

Prog Urol. 2011 Nov;21(12):823-8